Compass Therapeutics, Inc.

CMPX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$46,212$22,856$41,048$43,483
Short-Term Investments$173,683$78,093$71,587$83,239
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,225$5,246$11,510$6,029
Total Curr. Assets$221,120$106,195$124,145$132,751
Property Plant & Equip (Net)$9,571$9,935$6,738$7,084
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$568$0$0
Tax Assets$0$0$0$0
Other NC Assets$568$0$568$568
Total NC Assets$10,139$10,503$7,306$7,652
Other Assets$0$0$0$0
Total Assets$231,259$116,698$131,451$140,403
Liabilities
Payables$3,095$2,595$1,577$2,249
Short-Term Debt$633$271$109$338
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$8,684$10,992$13,214$6,287
Total Curr. Liab.$12,412$13,858$14,900$8,874
LT Debt$9,234$9,633$6,272$6,296
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$1
Total NC Liab.$9,234$9,633$6,272$6,297
Other Liabilities$0$0$0$0
Cap. Leases$9,867$0$6,381$6,634
Total Liabilities$21,646$23,491$21,172$15,171
Equity
Pref Stock$0$0$0$0
Common Stock$53$14$14$13
Retained Earnings-$415,456-$401,197-$381,316-$364,683
AOCI$274$208$190$210
Other Equity$624,742$494,182$491,391$489,692
Total Equity$209,613$93,207$110,279$125,232
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$231,259$116,698$131,451$140,403
Net Debt-$36,345-$12,952-$34,667-$36,849